Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world

BACKGROUND: There has been a paradigm shift in the treatment of Hepatitis C (HCV) from the interferon-era to direct-acting antiviral (DAA) drugs. Cure of HCV for the key risk group, those with a history of injecting drug use, may provide a range of benefits to an individual’s quality of life that ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Donaldson, Sarah R., Radley, Andrew, Dillon, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178822/
https://www.ncbi.nlm.nih.gov/pubmed/35676732
http://dx.doi.org/10.1186/s13011-022-00475-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178822/
https://www.ncbi.nlm.nih.gov/pubmed/35676732
http://dx.doi.org/10.1186/s13011-022-00475-1

Ejemplares similares